About us | Advertise with us | Contact us
Posted: 19 September 2018 | Mike Stones | No comments yet
Tannin acid injections to treat cardiovascular disease may avoid the need for surgery, according to research from Korea…
Tannin acid injections to treat cardiovascular disease may avoid the need for surgery.
Treating cardiovascular and related vascular diseases using tannin acid injections may avoid the need for surgery, reveals a new study from the Korea Advanced Institute of Science and Technology (KAIST).
Researchers developed a heart-targeting drug delivery technology using tannin acid via intravenous systemic injection. The method can be applied to the development of a variety of new protein-based drugs, according to the research team.
Joint research leader Professor Haeshin Lee, from the Department of Chemistry, said, “Although there have been numerous drugs related to heart disease, so far, there has not been efficient drug delivery to the heart. So, this technology will be able to reformulate existing drugs into new and more efficient drugs.”
Cardiovascular-circulatory disease is the second leading cause of death in Korea. The disease typically leads to myocardial infarctions caused by poor oxygen and nutrient supply due to narrowed coronary arteries and poor blood flow to the heart.
Conventional methods of drug delivery to the heart need surgical procedures involving incisions in the chest wall and bones. Clinics still rely on surgical procedures despite many research projects which have focused on developing chemotherapeutic drugs and therapeutic proteins. Drug delivery can be an alternative but is challenging because the ceaseless pulsing of the heart and big exchanges of blood mean administered therapeutics do not stay inside the heart very long, said the researchers.
The researchers selected tannic acid – known for giving bitter taste to wines and one of the most abundant polyphenols found in plants – because of properties enabling its use as a multifunctional coating molecule. Prof Lee and his team developed protein and peptide therapeutics with tannic acid and succeeded in targeting protein and peptide therapeutics to the heart.
Coated on the surface of a granulated protein complex, tannic acid helped to maintain cardiac function because it adhered to extracellular matrices, elastin, and collagens in heart tissues. This enabled the protein to stay attached to the heart tissue for longer.
Tannic-acid-modified proteins stayed in blood vessels five days longer compared with protein-only injections, according to the team. They also found that tannic acid protein complexes do not show cardiac toxicity and do not cause noticeable pathology.
The team is continuing to develop biomaterials for medical applications by testing various polyphenolic materials that feature adhesive and coating properties, including tannic acid. A mixture of tannic acid and fibroblast growth factors were injected into animal models with myocardial infarctions.
After four weeks, they confirmed that the infarction was reduced and the left ventricular pressure and cardiac output achieved almost normal levels.
The joint research leader was Dr Ki-Suk Kim from the institute’s Predictive Model Research Center.
The research was published in Nature Biomedical Engineering.
Formulation, Ingredients, New Drug Application (NDA), protein structure, Research & Development (R&D)
KAIST Department of Chemistry, Korea Advanced Institute of Science and Technology, Nature Biomedical Engineering
Formulation, Ingredients, New Drug Application (NDA), protein structure, Research & Development (R&D)
KAIST Department of Chemistry, Korea Advanced Institute of Science and Technology, Nature Biomedical Engineering
All subscriptions include online membership, giving you access to the journal and exclusive content.
By Thomas B Cueni (IFPMA)
Your email address will not be published. Required fields are marked *
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Write for us | Advertise with us
European Pharmaceutical Review is published by: Russell Publishing Ltd. Court Lodge Hogtrough Hill Brasted, Kent, TN16 1NU United Kingdom
© Russell Publishing Limited, 2010-2022. All rights reserved.
Website development by e-Motive Media Limited.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorised as ”Necessary” are stored on your browser as they are as essential for the working of basic functionalities of the website. For our other types of cookies “Advertising & Targeting”, “Analytics” and “Performance”, these help us analyse and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these different types of cookies. But opting out of some of these cookies may have an effect on your browsing experience. You can adjust the available sliders to ‘Enabled’ or ‘Disabled’, then click ‘Save and Accept’. View our Cookie Policy page.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
CookieDescriptioncookielawinfo-checkbox-advertising-targetingThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".cookielawinfo-checkbox-analyticsThis cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".cookielawinfo-checkbox-necessaryThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".cookielawinfo-checkbox-performanceThis cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".PHPSESSIDThis cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.viewed_cookie_policyThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.zmember_loggedThis session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.